TARGET-NASH is a longitudinal observational cohort study of patients being managed for NASH and related conditions across the entire spectrum NAFLD in usual clinical practice. TARGET-NASH is a research registry of patients with NAFL or NASH within academic and community real-world practices maintained in order to assess the safety and effectiveness of current and future therapies.
Age range
2 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Establish an understanding of the current natural history of NASH at academic and community medical centers
Timeframe: 10 years
Evaluate NASH treatment regimens being used in clinical practice
Timeframe: 10 years
Examine populations underrepresented in phase II-III clinical trials
Timeframe: 10 years
Evaluate optimal duration and combination of NASH therapies to achieve clinical response and clinical remission
Timeframe: 10 years
Examine liver histology
Timeframe: 10 years
Estimate adverse event frequency and severity and describe management practices
Timeframe: 10 years
Evaluate the impact of NASH therapies on medical co-morbidities
Timeframe: 10 years